Kisspeptin-10

• 10mg lyophilized peptide

• GnRH secretion via Kiss1 receptor (GPR54) signaling, triggering GnRH release from the hypothalamus and stimulating pituitary output of luteinizing hormone (LH) and follicle stimulating hormone (FSH), supporting ovarian function and sperm production endpoints.
• Puberty and fertility regulation through control of gonadotropins, influencing puberty onset and downstream reproductive hormone signaling tied to menstrual cycle regulation and testosterone production.
• Reproductive hormonal balance support by helping maintain appropriate testosterone, estrogen, and progesterone signaling, supporting hormonal homeostasis in both males and females.

Kisspeptin-10 is frequently studied for

• Fertility enhancement research interest, including ovulation induction paradigms in females and spermatogenesis support endpoints in males.
• Puberty regulation applications in delayed puberty contexts, supporting initiation of pubertal development in models involving hormonal imbalance.
• Endocrine disorder relevance in research settings such as polycystic ovary syndrome (PCOS) and hypogonadotropic hypogonadism, where restoring hormonal balance is a common target.

Kisspeptin-10 is generally characterized as well tolerated in clinical studies, with no significant side effects noted in the provided source discussion. Because it directly affects hormonal regulation, it is typically treated as a compound that warrants closer monitoring in endocrine sensitive contexts, including PCOS, hormone sensitive cancers, or other endocrine disorders.